跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAPA 250 SUPPOSITORY 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
NAPA 250 SUPPOSITORY 250 MG
Approved
THERAPEUTIC
NAPA 250 SUPPOSITORY 250 MG
BEXIMCO PHARMACEUTICALS LTD (BANGLADESH)
🇸🇬 Health Sciences Authority
Approval Date
Dec 8, 1998
Approval ID
61c5e335eccc0e28
Company
BEXIMCO PHARMACEUTICALS LTD (BANGLADESH)
Type
Therapeutic
Approval Details
Approval Id
61c5e335eccc0e28
Drug Name
NAPA 250 SUPPOSITORY 250 MG
Product Name
NAPA 250 SUPPOSITORY 250 MG
Approval Number
SIN10522P
Approval Date
1998-12-08
Registrant
PHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence Holder
PHARMATECH MEDICAL ENTERPRISE PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SUPPOSITORY
Route Of Administration
RECTAL
Atc Code
N02BE01
Atc Item Name
paracetamol
Pharma Manufacturer Name
PHARMATECH MEDICAL ENTERPRISE PTE. LTD.
Company Detail Path
/organization/pharmatech-medical-enterprise-pte-ltd
Active Ingredients
PARACETAMOL
250 mg
PARACETAMOL
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 8, 1998
Approval ID
61c5e335eccc0e28
Type
Therapeutic
Back to HSA Approvals